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Extracellular calcium antagonizes forskolin-induced aquaporin
2 trafficking in collecting duct cells.
Background. Urinary concentrating defects and polyuria are
the most important renal manifestations of hypercalcemia and
the resulting hypercalciuria.
In this study, we tested the hypothesis that hypercalciuria-
associated polyuria in kidney collecting duct occurs through an
impairment of the vasopressin-dependent aquaporin 2 (AQP2)
water channel targeting to the apical membrane possibly involv-
ing calcium-sensing receptor (CaR) signaling.
Methods. AQP2-transfected collecting duct CD8 cells were
used as experimental model. Quantitation of cell surface AQP2
immunoreactivity was performed using an antibody recogniz-
ing the extracellular AQP2 C loop. Intracellular cyclic adeno-
sine monophosphate (cAMP) accumulation was measured in
CD8 cells using a cAMP enzyme immunoassay kit. To study
the translocation of protein kinase C (PKC), membranes or cy-
tosol fractions from CD8 cells were subjected to Western blot-
ting using anti-PKC isozymes antibodies. The amount of F-actin
was determined by spectrofluorometric techniques. Intracellu-
lar calcium measurements were performed by spectrofluoro-
metric analysis with Fura-2/AM.
Results. We demonstrated that extracellular calcium (Ca2+ o)
(5 mmol/L) strongly inhibited forskolin-stimulated increase in
AQP2 expression in the apical plasma membrane. At least three
intracellular pathways activated by extracellular calcium were
found to contribute to this effect. Firstly, the increase in cAMP
levels in response to forskolin stimulation was drastically re-
duced in cells pretreated with Ca2+ o compared to untreated
cells. Second, Ca2+ o activated PKC, known to counteract vaso-
pressin response. Third, quantification of F-actin demonstrated
that Ca2+ o caused a nearly twofold increase in F-actin content
compared with basal conditions. All these effects were mim-
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icked by a nonmembrane permeable agonist of the extracellular
CaR, Gd3+.
Conclusion. Together, these data demonstrate that extracel-
lular calcium, possibly acting through the endogenous CaR, an-
tagonizes forskolin-induced AQP2 translocation to the apical
plasma membrane in CD8 cells. In hypercalciuria, this mecha-
nism might blunt water reabsorption and prevent further cal-
cium concentration, thus protecting against a potential risk of
urinary calcium-containing stone formation.
Vasopressin acutely regulates the water permeability
of the kidney collecting duct by inserting aquaporin 2
(AQP2) in intracellular vesicles to the luminal plasma
membrane. As a consequence, water is reabsorbed, lead-
ing to urine concentration [1–4]. In several pathologic
conditions, characterized by urinary concentrating de-
fects such as nephrogenic diabetes insipidus (NDI), pos-
tobstructive polyuria, and acute and chronic renal failure
(CRF), the apical expression of AQP2 is drastically re-
duced or even absent.
Urinary concentrating defects and polyuria are the
most important renal manifestations of hypercalcemia
and the resulting hypercalciuria. The mechanisms under-
lying the external calcium dependency of hypercalciuria-
associated polyuria and subsequent alteration in AQP2
levels at the apical membrane are unknown but it is
known that chronic hypercalcemia is associated with re-
duced NaCl reabsorption in the thick ascending limb.
An increase in plasma Ca2+ concentrations stimulate
the basolateral calcium-sensing receptor (CaR) in the
medullary thick ascending limb and inhibit the apical
K+ conductance essential for maintaining the func-
tion of Na/K/Cl cotransporter [5]. Therefore, hypercal-
cemia causes a decrease in sodium reabsorption in the
medullary thick ascending limb providing an explanation
for the defect in diluting capacity [6]. Besides these ef-
fects, reduced concentrating ability in the collecting duct
can contribute to the overall water reabsorption defect
observed in hypercalciuria.
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We recently demonstrated that in primary nocturnal
enuresis, a frequent disease in children, characterized by
nocturnal polyuria, hypercalciuria was associated with al-
terations of urinary AQP2 levels indicating clearly that
Ca2+o activity modulates AQP2 excretion in the urine
[7]. A relatively useful therapeutic intervention based on
a low calcium diet demonstrated that amelioration of clin-
ical is accompanied by regulation of urine output through
remodulation of AQP2 expression/trafficking [8].
The close relation between hypercalciuria and AQP2
dysregulation was previously suggested by Sands et al [9]
and, more recently, by Puliyanda et al [10]. These authors
reported that, in rats, dihydrotachysterol (DHT) induces
hypercalcemia/hypercalciuria associated with polyuria
and AQP2 water channel down-regulation. A calcium-
dependent calpain activation was proposed to modulate
AQP2 levels through AQP2 proteolysis [10]. The kidney
is a key organ for calcium homeostasis, and its ability to
sense extracellular calcium levels in the urinary filtrate
and the interstitial fluid is due to the extracellular CaR,
which is expressed in multiple sites along the nephron [11,
12]. The renal CaR plays a crucial role in the regulation
of divalent mineral cation transport [11, 13–15].
Inherited human diseases due to CaR gene mutations
demonstrate the relevance of CaR in divalent mineral
ion as well as water reabsorption. Heterozygous muta-
tions causing CaR loss of function resulting in a lower
sensitivity of the CaR to extracellular calcium such as in
the familial hypocalciuric hypercalcaemia (FHH).
In this condition the kidney excretes less calcium
causing relative hypocalciuria [16–18]. In contrast, CaR
gain of function mutations like in autosomal-dominant
hypocalcemia (ADH) lead to hypercalciuria [19]. CaR
mutations have been demonstrated to alter renal water
handling, supporting a role for the CaR in integrating
mineral ion and water metabolism [20, 21]. Renal CaRs
are expressed on the apical membrane of proximal tubule
and on the basolateral membrane of thick ascending limb
and in a diffuse pattern in the distal convoluted tubule
[22]. In the collecting duct, CaRs are expressed at the
apical membrane [23] where they might sense urinary
calcium levels and influence AQP2 trafficking, providing
a link between calcium and water homeostasis.
This work was undertaken to clarify the signal trans-
duction pathways linking urinary calcium levels to AQP2
expression/trafficking in the collecting duct. The possible
functional involvement of CaR in these events was also
evaluated.
METHODS
Cell culture
CD8 cells were established by stably transfecting the
RC.SV3 rabbit cortical collecting duct cells with the
cDNA encoding rat AQP2 [24].
CD8 cells were grown at 37◦C under a humidified
atmosphere of 5% CO2-95% air in Dulbecco’s modi-
fied Eagle’s medium (DMEM)-Ham’s F-12 1:1 (vol/vol)
medium supplemented with 20 mmol/L sodium bicarbon-
ate, 20 mmol/L Hepes, and 5% newborn calf serum.
Reverse transcription-polymerase chain reaction (RT-
PCR) and sequencing of CaR cDNA from CD8 cells
Total RNA was extracted from confluent CD8 cells by
the TRIzol extraction method (TRIzol Reagent) (Life
Technologies, Gaithersburg, MD, USA). The RNA was
then used to amplify fragments of cDNA from the CaR
by degenerate RT-PCR. The degenerate primers CaR-1U
(5′-ATCTGGCTGGCYAGCGAGGC-3′) and CaR-2D
(5′-GCAATGGAGTAGACKGCTAAG-3′) were used.
The oligonucleotides were designed based on the CaR
nucleotide sequences from rat, human, and mouse.
A positive control was performed by using primers
specific for b-actin cDNA (5′-CAGATCATGTTTGA
GACCTT-3′) and (5′-CGGATGTCMACGTCACACA
CTT-3′). The CaR cDNA amplified from the CD8 cells
was cloned into the EcoRI/EcoRI site of the pCR2.1 vec-
tor (TA Cloning Kit; Invitrogen, San Diego, CA, USA)
following a TA strategy. Cloned DNA fragments were
controlled by sequencing.
Transfection of CD8 cells with human CaR-green fluo-
rescent protein (GFP)
CaR sequence was generated by excising the 1373 bp
EcoRI fragment from the human CaR sequence and
cloning it into pcDNA3.1. A vector expressing a carboxy-
terminal GFP-tagged human CaR was generated as pre-
viuosly described [25].
Transfection was performed by use of lipofectin. Cells
were plated into 45 mm-dishes for 15 hours before trans-
fection. Cells were washed with serum-free medium and
then incubated for 12 hours at 37◦C with 2 mL of serum-
free medium containing 20 lg of lipofectin and 5 lg of
recombinant plasmid. Cells were washed and then grown
for 48 hours in DMEM supplemented with 5% fetal
calf serum (FCS). Cells were trypsinized and plated on
140 mm diameter dishes. A selection of cells containing
transfected DNA was obtained with a medium contain-
ing Hygromicin (500 lg/mL) for 10 to 15 days. Resistant
clones were isolated and transferred to separate culture
dishes for expansion and analysis.
Western blotting
For CaR detection by Western blotting in CD8 cells and
in rat kidney papilla a technical procedure for intramem-
brane protein extraction was followed. Confluent mono-
layer of CD8 cells were rapidly scraped, pelleted in a
microfuge, and homogenized by repeated freeze-thawing
cycles (liquid nitrogen/37◦C). The obtained homogenate
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was extracted for 5 minutes in a solubilization buffer
containing 150 mmol/L NaCl, 0.5 mmol/L ethylenedi-
aminetetraacetic acid (EDTA), 0.5 MgCl2 10 mmol/L
Tris, pH 7.4, 1% Triton X-114 in presence of 1 mmol/L
phenylmethylsulfonyl fluoride (PMSF), 1 mg/mL leu-
peptin, and 1 mg/mL pepstatin A at 4◦C. Samples was
then centrifuged at 14,000 × g for 15 minutes at 4◦C
to separate detergent-soluble fraction and detergent-
insoluble fraction. The detergent insoluble fraction was
completely solubilized in 1% NP-40 and 0.5% Triton X-
100 in phosphate-buffered saline (PBS). The detetergent
soluble fraction was used for Western blotting analysis
(see below). For CaR detection in rat kidney, 500 lg of
purified endosomes were extracted in 100 lL of the sol-
ubilization buffer followed by the same procedure em-
ployed for CD8 cells. AQP2 containing endosomes from
rat papillae were prepared as described [26].
Equal amount of the proteins were resuspended in
Laemmli buffer, heated to 60◦C for 10 minutes and
subjected to 8% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE). Gels were transferred
to Immobilon-P membrane (Millipore, Bedford, MA,
USA), blocked in blotting buffer (in mmol/L): 150 NaCl,
20 Tris-HCl, pH 7.4, and 1% Triton X-100, containing
5% nonfat dry milk, for 1 hour. The membranes were
incubated with antiserum to CaR (Alexis Biochemicals,
San Diego, CA, USA) (1:500) overnight at 4◦C in blot-
ting buffer, washed in several changes of the same blot-
ting buffer. Immunolabeling controls were performed
using preabsorption of the immune serum with the im-
munizing peptide for 2 hours at RT (1000-fold excess).
The membranes were incubated with goat antirabbit IgG
peroxidase-conjugated (Sigma-Aldrich Corporation, St.
Louis, MO, USA) (1:5000 dilution) in the blotting buffer
and visualized using the ECL-PLUS detection system
(Bio-Rad, Hercules, CA, USA).
cAMP measurements
Intracellular cAMP accumulation was measured in
CD8 cells cultured in 24-well plates to confluence
(700,000 cells/wells). Cells were left under control condi-
tions or were treated with 5 mmol/L calcium for 15 min-
utes or with 300 lmol/L Gd3+ for 15 minutes at 37◦C in
PBS-Ca2+/Mg2+ (1 mmol/L Ca2+ and 1 mmol/L Mg2+)
and 100 lmol/L IBMX. Cells were then stimulated with
10−4 mol/L forskolin for 15 minutes at 37◦C. The reaction
was stopped by cooling the 24-well plates in ice. cAMP
concentrations were measured in pmol per 106 cells and
reported as a percentage of control cells, using a cAMP
enzyme immunoassay kit (Cayman Chemical Company,
Ann Arbor, MI, USA) as previously described [27].
Intracellular calcium measurements
Alterations of intracellular calcium concentration in-
duced by a nonmembrane permeable CaR agonist, Gd3+,
were determined by a spectrofluorometric technique.
CD8 cells were grown to confluence on glass cover-
slips. Cells were loaded with 10 lmol/L Fura-2/AM for
30 minutes in serum-free culture medium at 37◦C. Cells
were then washed once with a Fura-2-free bath solution
(in mmol/L): 135 NaCl, 5.5 KCl, 1 MgCl2, 1.26 CaCl2,
0.44 KH2PO4, 0.64 Na2HPO4, 3 NaHCO3, 5.5 glucose,
and 20 Hepes, pH = 7.4. The coverslips were inserted
into a specially designed cuvette as previously described
[28]. The cuvette was connected to a perfusion system
for solution changes, and fluorescence was recorded on a
Shimadzu RF-5001 spectrofluorometer. The cells were al-
ternatively illuminated with 340 and 380 nm light, and flu-
orescence at emission wavelength 510 nm was recorded.
The cells were exposed to increasing Ca2+o concentra-
tions or to 300 lmol/L Gd3+ in the bath solution, and in-
tracellular calcium concentration was calculated from the
emission fluorescence ratio of the two excitation wave-
lengths using the formula: [Ca2+]i = Kd (R − Rmin)/(Rmax
− R) where Kd (dissociation constant) of Fura-2 for
[Ca2+]i was 224 nmol/L. Each sample was calibrated
by the addition of 50 lmol/L digitonin (Rmax) followed
by 10 mmol/L ethyleneglycoltetraacetate (EGTA)/Tris
(Rmin).
Actin polymerization assay
The amount of F-actin was determined as described
previously [29–31]. Briefly, CD8 cells were seeded on
microplates 2 days before the experiments. Cells were
left untreated (PBS-Ca2+/Mg2+) or stimulated with
10−4 mol/L forskolin for 15 minutes, or preincubated with
5 mmol/L calcium for 15 minutes or with 300 lmol/L
Gd3+ for 15 minutes in PBS-Ca2+/Mg2+. The treatments
were stopped by addition of a solution containing 3.7%
formaldehyde, 0.1% Triton X-100, 0.25 lmol/L TRITC-
phalloidin in 20 mmol/L potassium phosphate, 10 mmol/L
PIPES, 5 mmol/L EGTA, and 2 mmol/L MgCl2, pH = 6.8.
After staining for 1 hour, cells were washed with PBS
and extracted with 800 mL cold methanol. The fluores-
cence (540/565 nm) was read in an RF-5301PC fluorom-
eter. The values obtained were then analyzed by the
Student t-test.
Quantitation of AQP2 cell surface immunoreactivity
CD8 cells were either left under control condi-
tions (PBS-Ca2+/Mg2+), or stimulated with 10−4 mol/L
forskolin for 15 minutes at 37◦C in PBS-Ca2+/Mg2+ in
the presence or in the absence of 300 lmol/L Gd3+ or
5 mmol/L calcium. Cells were fixed and incubated with
an antibody recognizing the extracellular AQP2 C loop
(1:300 dilution in PBS-gelatin) for 11/2 hour at 4◦C. Quan-
titation of cell surface immunoreactivity was performed
as described [32].
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Fig. 1. Expression of calcium-sensing re-
ceptors (CaR) in CD8 cells. (A) Reverse
transcription-polymerase chain reaction (RT-
PCR) amplification of CaR cDNAs expressed
in CD8 cells. Total RNA from confluent CD8
cells was subjected to reverse transcription
followed by PCR amplification using degen-
erate primers for the coding region of known
CaR (see Methods section for experimen-
tal details). Bands of 410 bp corresponding
to CaR were amplified. As a positive con-
trol, parallel RT-PCR experiments with to-
tal RNA extracted from rat kidney were per-
formed. Results shown are representative of
at least three separate experiments. (B) Con-
focal analysis and the xz reconstruction (inset)
performed on CD8 cells transfected with gel-
filtered platelets (GFP)-tagged CaR. (C) Im-
munoblotting of Triton X114 soluble fraction
from CD8 cell, CD8 CaR-GFP transfected
cells and rat kidney endosomes. Each lane
was loaded with 60 lg proteins. Blotted pro-
teins were probed with anti-CaR serum (1:500
dilution) (Alexis Biochem) and immunoreac-
tive bands were revealed with chemilumines-
cence ECL-PLUS (Bio-Rad). The same sam-
ples were incubated with anti-CaR antibody,
which has been reabsorbed with the immu-
nizing peptide (preadsorbed antibody). Aster-
isk corresponds to the CaR-GFP glycosylated
form. Results shown are representative of at
least three separate experiments.
Translocation of protein kinase C (PKC)
CD8 cells homogenate, prepared as described above,
were subjected to 10% SDS-PAGE and transferred to
Immobilon-P membrane (Millipore). Membranes were
blocked in blotting buffer (in mmol/L): 150 NaCl, 20
Tris-HCl, pH 7.4, and 1% Triton X-100, containing 5%
nonfat dry milk for 1 hour and incubated with anti-PKC
isozymes (a, b , c, d, ε, ι, k, h, and g) monoclonal anti-
body (PKC Sampler Kit) (Transduction Laboratories),
overnight at 4◦C in blotting buffer. The membranes were
incubated with goat antimouse IgG alkaline phosphatase
conjugated (Sigma Chemical Co.) (1:5000 dilution) and
revealed with 1-Step(tm) NBT/BCIP (Pierce, Rockford,
IL, USA).
To study the membrane/cytosol expression of PKC,
subconfluent monolayers of CD8 cells grown on 150 cm2
culture Petri dishes were left under basal condition (PBS-
Ca2+/Mg2+) or treated with 5 mmol/L Ca2+o or with
300 lmol/L Gd3+ in PBS-Ca2+/Mg2+ and then homog-
enized in ice-cold homogenization buffer [10 mmol/L
Tris-HCl (pH 7.4), 0.25 mol/L sucrose, 2 mmol/L
EDTA, 1 mmol/L dithiothreitol (DTT), 5 mmol/L MgCl,
1 mmol/L PMSF, and a protease inhibitor cocktail (Sigma
Chemical Co.)] and centrifuged at 100,000 × g for 1 hour
at 4◦C (Optima XL-100K ultracentrifuge) (Beckman In-
struments, Palo Alto, CA, USA). The resulting pellets
and supernatants were collected and referred to as mem-
brane and cytosolic fractions, respectively. Membranes
or cytosol fractions were solubilized in Laemmli buffer,
heated to 60◦C for 10 minutes, and subjected to 10% SDS-
PAGE and transferred to Immobilon-P membrane (Milli-
pore). Membranes were probed with anti-PKC isozymes
antibodies as described above.
Data analysis and statistics
Data are expressed as mean ± SE. Statistical analysis
was performed by unpaired Student t test or by one-way
analysis of variance (ANOVA) and Tukey’s test for mul-
tiple comparisons. Band intensities in Western blotting
analysis were quantitated by densitometric analysis us-
ing National Institutes of Health Images (NIH) software.
RESULTS
CD8 cells express functional endogenous CaR
To test the expression of CaR in CD8 cells, RT-PCR
studies were carried out. The RT-PCR experiments were
performed with total RNA extracted from confluent CD8
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cells using degenerated primers, based on conserved re-
gions of CaR nucleotide sequences (see the Methods sec-
tion). As shown in Figure 1A, a fragment having an ex-
pected size of 410 bp was amplified both from rat kidney
and CD8 cell total RNA. The specificity of the cDNAs
amplified by RT-PCR was confirmed by cloning and se-
quencing of the PCR fragment. The fragment was found
to share 91% identity with the homosapiens CaR mRNA.
In the kidney collecting duct, CaR has been localized to
the apical membrane of principal cells [23]. To analyze the
localization of the CaR, CD8 cells were stably transfected
with the human CaR-GFP. This was necessary because of
the lack of immunoreactivity of the available antibody in
immunolocalization studies. Confocal analysis and the xz
reconstruction showed that GFP-tagged CaR was local-
ized both to the basolateral and apical membrane domain
with an apparent more pronounced lateral localization
(Fig. 1B). A very low intracellular staining was observed.
To analyze the expression of the CaR as proteins, West-
ern blot experiments were carried out using specific an-
tibodies. CD8 cells homogenate or endosomes from rat
kidney papillae were treated with Triton X-114 as de-
scribed in the Methods section. Figure 1C shows the West-
ern blotting of the Triton X-114 soluble fraction from
CD8, CaR-GFP-transfected CD8 cells and rat kidney
probed with anti-CaR antibodies. A 120 kD band corre-
sponding to the monomeric nonglycosylated form of CaR
as well as a stronger 160 to 170 kD band corresponding to
the mature glycosylated form in both CD8 cell and CaR-
GFP-transfected CD8 cells were stained. As expected, in
CaR-GFP transfected cells, besides the endogenous CaR
immureactive bands, an additional band around 200 kD
(about 30 kD greater than the size of the endogenous
mature receptor) (Fig. 1C, asterisk) was detected corre-
sponding to the GFP-tagged CaR. Moreover, a faint band
around 150 kD was also stained, likely corresponding to
the monomeric nonglycosylated GFP-tagged CaR.
In the Triton-X114 soluble fraction of endosomes from
rat papilla the antibody recognized the conventional
120 kD band and a stronger140 kD band corresponding to
the glycosylated form of CaR. An additional band was vis-
ible over 200 kD probably corresponding to the dimeric
form of CaR. Compared with CD8 cells, the glycosylated
form of the CaR showed a slightly lower molecular weight
probably due to the different glycosylation pattern of the
protein in rabbit and rat, respectively.
The binding of the anti-CaR polyclonal antibody to
the CaR bands was shown to be specific because it was
ablated by preincubation of antibody with excess immu-
nizing peptide (preadsorbed antibody).
To determine whether the CaR in CD8 cells is a func-
tional receptor, we tested alteration in intracellular Ca2+
concentrations in response to increasing Ca2+o or to the
CaR agonist Gd3+. Raising Ca2+o from 0.2 mmol/L to
2.5 or to 5 mmol/L caused a dose-dependent elevation
in [Ca2+]i from 67.5 ± 9.1 nmol/L to 120 ± 12 nmol/L
or to 305 ± 20.5 nmol/L, respectively (Fig. 2A and A′).
When CD8 cells were perfused with 300 lmol/L Gd3+,
[Ca2+]i concentration increased by about 1.5-fold over
basal intracellular Ca2+ levels (from 80 ± 6.3 nmol/L to
110.4 ± 6.7 nmol/L) (Fig. 2B and B′). Similar results were
obtained in the absence of Ca2+o, confirming that CaR
stimulation induces the calcium release from the intra-
cellular stores (Fig. 2B, inset).
Extracellular calcium impairs forskolin-induced cell
surface expression of AQP2
AQP2 targeting in response to forskolin was quanti-
fied in the presence or in the absence of 5 mmol/L Ca2+o
or in the presence of 300 lmol/L Gd3+. To this end, cell
surface immunoreactivity of anti-AQP2 antibody raised
against a peptide reproducing the extracellular AQP2 C
loop was evaluated under different experimental condi-
tions (Fig. 3). As expected, in the presence of physiologic
extracellular calcium concentrations, forskolin increased
cell surface expression of AQP2 by about twofold, as a
consequence of the increase in intracellular cAMP levels
as shown previously (Fig. 3) [32]. In contrast, in the pres-
ence of 5 mmol/L Ca2+o or Gd3+, forskolin did not sig-
nificantly increase the cell surface abundance of AQP2.
These results demonstrate an antagonistic effect of ex-
tracellular calcium on forskolin-stimulated AQP2 traf-
ficking, suggesting that CaR plays a modulatory role in
vasopressin-induced antidiuresis.
cAMP levels are drastically reduced in forskolin-
stimulated cells in the presence of Ca 2+o and GD3+
We next investigated the intracellular signals down-
stream of extracellular calcium and Gd3+ stimulation and
leading to a reduction of AQP2 targeting upon forskolin
stimulation. As [Ca2+]i regulates cAMP levels in many
cell types through interaction of calcium on cAMP syn-
thesis and/or hydrolysis [33, 34], we first analyzed whether
a forskolin-elicited increase in cAMP levels is influenced
by Ca2+o. When CD8 cells were stimulated with forskolin
(10−4 mol/L, 15 minutes), cAMP levels increased by 14.79
± 1.6-fold (N = 18) with respect to control cells (Fig. 4).
In contrast, when forskolin stimulation was performed in
the presence of 5 mmol/L Ca2+o, a drastic reduction in the
rise of cAMP levels was measured, corresponding to 4.40
± 1.0-fold (N = 6) and 4.0 ± 0.3-fold (N = 10), respec-
tively (Fig. 4). cAMP levels in response to forskolin stim-
ulation were also measured in the presence of 300 lmol/L
Gd3+, a known CaR activator. Interestingly, in the pres-
ence of Gd3+, forskolin stimulation reduced the cAMP
concentration by about 50% (from 14.79 ± 1.6-fold to
7.45 ± 1.62-fold, N = 10) (Fig. 4).
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Fig. 2. Effect of Ca 2+o and Gd3
+ on [Ca2+]i concentration in CD8 cells. (A) Representative trace of the time course of the emission ratio (340/380
excitation) in Fura-2–loaded CD8 cells perfused with increasing concentration of extracellular calcium. (A’) Mean ± SE of [Ca2+]i concentrations
in basal condition, after 2.5 mmol/L Ca2+ and after 5 mmol/L Ca2+ (N = 3). ∗P < 0.05; ∗∗∗P < 0.001 vs. values calculated in basal condition by
one-way analysis of variance (ANOVA and Tukey’s multiple comparison test). (B) Representative experiment showing the effect of 300 lmol/L
Gd3+ over 300 seconds. Similar results were obtained in the absence of Ca2+ o, confirming that calcium-sensing receptor (CaR) stimulation induces
the calcium release from the intracellular stores (inset). (B’) Mean ± SE of [Ca2+]i concentrations in control and Gd3+-treated cells (N = 3). P <
0.05 vs. values calculated in control cells by Student t test.
Extracellular calcium causes PKC activation
In various cell types, elevation of extracellular calcium
elicits a complex signaling cascade leading to phospholi-
pase C (PLC)-dependent stimulation of PKC [35]. Since
it has been suggested that PKC activation may mediate
endocytosis of AQP2 in renal cells [36], we tested whether
CaR activators, Ca2+o and Gd3+, could cause PKC acti-
vation in CD8 cells. We first determined the expression
of PKC isoforms in CD8 cells by Western blotting using
isoform-specific antibodies.
In cell homogenates from CD8, five different isoforms
of PKC (a, d, ε, ι, and k) were found to be expressed,
while PKC isoforms b , c, h, and g were not detectable
(Fig. 5A). Activation of PKC isoforms was assessed by
their ability to translocate from cytosol to membrane as a
consequence of CaR signaling cascade (Fig. 5B, B′, C, and
C′). Phorbol 12-myristate 13-acetate (PMA) was used as
positive control. Under basal condition, 50% PKCa and
26.5% PKCε were expressed in the membrane fraction.
Exposure to 5 mmol/L Ca2+o or 300 lmol/L Gd3+caused
an enrichment of both PKCa and ε in the membrane frac-
tion (PKCa from 50 ± 3.7% to 76.5 ± 5.6%; from 50 ±
3.7% to 74.5 ± 4%, respectively; PKCε from 26.5 ± 4.9%
to 58.3 ± 3.2% and from 26.5 ± 4.9% to 62 ± 0.5%,
respectively). A concomitant proportional decrease of
PKCa and PKCε in the cytosol fraction was observed.
Neither Ca2+o nor Gd3+ had any effect on the cellular
localization of PKC isoforms d, ι, and k (data not shown).
Ca2+o and GD3+ induce formation of F-actin-containing
stress fibers
In human embryonic kidney (HEK)-293 cells trans-
fected with CaR, a CaR-mediated increase in membrane-
associated RhoA has been demonstrated, suggesting a
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Fig. 3. Determination of cell surface aquaporin 2 (AQP2) immunore-
activity. The anti-AQP2 C loop antibody was employed to monitor the
AQP2 abundance on the plasma membrane in CD8 cells as previously
described [28]. In untreated cells, forskolin stimulation increased the im-
munodetectable AQP2 on the cell surface by approximately twofold. In
contrast, when forskolin stimulation was performed in the presence of
5 mmol/L Ca2+ o or in the presence of 300 lmol/L Gd3+, this abolished
the forskolin-induced increase in cell surface expression of AQP2. Re-
sults shown represent the means ± SE of three separate experiments
in which about 4 × 106 cells (six separate wells) were tested for each
experimental condition in each experiment. Results are expressed as
percent of the value calculated under the respective basal conditions.
∗∗P < 0.01 vs. values calculated in control cells by Student t test.
CaR activation of Rho [37]. On the other hand, ear-
lier work from our laboratory demonstrated that in CD8
cells, stabilization of actin cytoskeleton obtained by ex-
pression of constitutive active Rho leads to formation of
F-actin-containing stress fibers and impairs AQP2 traf-
ficking upon forskolin exposure [38, 39].
We therefore evaluated whether treatment with CaR
agonists results in any alteration of actin assembly/
disassembly. The results of the quantitative actin poly-
merization assay are reported in Figure 6. Interestingly,
with respect to control cells, the F-actin content increased
dramatically after exposure to 5 mmol/L calcium or after
treatment with Gd3+ (from 79.2 ± 5.1 to 147.3 ± 14.4 and
111.7 ± 15.40, respectively). In contrast, forskolin stimu-
lation resulted in a significant (25%) decrease in F-actin
content.
Visualization of F-actin by phalloidin-TRITC was in
full agreement with the quantitative data obtained with
the actin polymerization assay (Fig. 7).
DISCUSSION
While it has been suggested that the luminal cal-
cium plays an important role in hypercalciuria-induced
polyuria, the molecular basis of this effect has not been
well established.
Previous studies have demonstrated the presence of
CaR protein in the apical membrane of rat collecting
duct [23]. In isolated perfused rat inner medullary col-
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Fig. 4. Measurements of intracellular cyclic adenosine monophos-
phate (cAMP) concentration in response to forskolin stimulation. CD8
cells were stimulated with forskolin (10−4 mol/L at 37◦C for 15 minutes)
in the absence or in the presence of 5 mmol/L Ca2+ o or of 300 lmol/L
of the calcium-sensing receptor (CaR) agonist Gd3+. Results are ex-
pressed as percent of the value calculated under the respective basal
conditions. P < 0.01; ∗∗∗P < 0.001 vs. values calculated in forskolin-
stimulated cells under control condition by Student t test.
lecting duct, acute increases in luminal calcium from 1
to 5 mmol/L calcium caused a rapid 30% reduction in
vasopressin-elicited Pf [24]. In addition, during sustained
hypercalcemia in chronically hypercalcemic rats, the Pf
in inner medullary collecting duct did not increase sig-
nificantly after vasopressin and was accompanied by an
87% reduction in AQP2 protein [9], which may con-
tribute to the lack of vasopressin responsiveness. Two
previous observations of ours prompted us to investigate
the possible mechanism(s) by which extracellular signal-
ing might modulate renal water handling through alter-
ation of AQP2 trafficking/expression. In the first, we have
shown that hypercalciuria is associated with alterations
of urinary AQP2 levels in enuretic children [7]. Second,
we demonstrated that lowering urinary calcium through a
low calcium diet normalized urinary AQP2 excretion and
improved the clinical symptoms [8]. Those observations
imply that an apical membrane signaling mechanism links
calcium and water permeability in the renal collecting
duct. In this study, we were therefore interested in identi-
fying the molecular mechanisms that link hypercalciuria-
associated polyuria and AQP2. The present contribution
demonstrates a clear regulatory role of extracellular cal-
cium on AQP2 trafficking in renal collecting duct cells.
To gain insights into a potential role for the CaR
in the regulation of AQP2 trafficking, we used AQP2-
transfected collecting duct CD8 cells [24]. This cell line
expresses endogenous CaR as assessed by RT-PCR and
sequencing using nested CaR primers. We report here
that, in CD8 cells, CaR activation caused an increase in
[Ca2+]i, as a result of calcium release from intracellu-
lar stores. Interestingly, both Ca2+o and Gd3+ drastically
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Fig. 5. Extracellular calcium and Gd3+ induce protein kinase C (PKC) translocation. (A) Immunoblots of PKCa, b , c, d, ε, h, ι, k, and g in CD8
cells homogenate. Results are representative of four independent experiments. (B and C) Translocation of PKCa and PKCε induced by calcium-
sensing receptor (CaR) agonists Ca2+ o and Gd3+. Results are representative of four experiments showing that PKCa and PKCε translocated from
the cytosol to the membrane fraction. (B’ and C’). Statistical analysis refers to relative PKC abundance in membrane and cytosol fractions upon
stimulation with Ca2+ o and Gd3+. Results are expressed as mean ± SE. Abbreviations are: C, cytosol; M, membrane (N = 4). ∗∗P < 0.01; ∗∗∗P <
0.001 vs. values calculated for the same subcellular fraction under control condition by one-way analysis of variance (ANOVA) and Tukey’s multiple
comparison test.
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Fig. 6. Actin polymerization assay. CD8 cells were left untreated or
stimulated with forskolin 10−4 mol/L for 15 minutes. Alternatively, cells
were preincubated with 5 mmol/L calcium for 15 minutes and with
Gd3+ 300 lmol/L for 15 minutes. To quantify F-actin content, cells were
then incubated in a solution containing TRITC-phalloidin and extracted
with methanol (see the Methods section for details). The fluorescence
(540/565 nm) was read and the values compared by one-way analysis of
variance (ANOVA) and Tukey’s multiple comparison test. ∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001.
(∼70%) inhibited forskolin-induced cAMP accumula-
tion. Consistent with that, we demonstrated that either
Gd3+ or 5 mmol/L Ca2+o strongly inhibited the forskolin-
stimulated increase in AQP2 immunoreactivity on the
Fig. 7. Fluorescence visualization of F-actin in CD8 cells. Cells were
left untreated (CTR) or incubated with 5 mmol/L Ca2+ o or with 300
lmol/L Gd3+ for 15 minutes at 37◦C. Cells were then fixed and F-actin
was stained with TRITC-conjugated phalloidin. Fluorescence was de-
tected by epifluorescence microscopy. Results shown are representative
of at least three separate experiments (bar = 10 lm).
apical plasma membrane, as assessed by AQP2 immuno-
quantification. These data demonstrate that CaR agonists
evoke an inhibition of forskolin-induced cAMP accumu-
lation and, in turn, this may be in part responsible for
the impaired AQP2 targeting to the plasma membrane.
Based on our in vitro results we can exclude that both
Ca2+o and Gd3+ confer inhibition of cAMP accumula-
tion through direct inhibitory protein G (Gi)-mediated
inhibition of adenylate cyclase, as this effect is measur-
able upon direct activation of the catalytic subunit of
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Fig. 8. Proposed mechanism by which Ca2+o, possibly acting through the calcium-sensing receptor (CaR), interferes with water reabsorption
in inner medullary collecting duct. Extracellular calcium activates the CaR, leading to increases in [Ca2+]i possibly via phospholipase C (PLC)
activation. This decreases forskolin-induced cyclic adenosine monophosphate (cAMP) levels through inhibition of adenyl cyclase and/or activation of
phosphodiesterase. In addition, [Ca2+]i and diacylglycerol (DAG) can activate calcium-dependent and calcium-independent protein kinase C (PKC)
isoform. CaR activation also results in formation F-actin–containing stress fibers probably through Rho activation. All these processes contribute to
reduction of forskolin-induced aquaporin 2 (AQP2) targeting to the plasma membrane thus decreasing water reabsorption from the lumen which
would contribute to impairment of kidney concentrating ability. Abbreviations are: ER, endoplasmic reticulum; PIP2, phosphatidylinositol-4,5-
bisphosphate; IP3, inositol-1,4,5-trisphosphate; AC, adenylate cyclase; Gs, a subunit of the s-type heterotrimeric G proteins; V2, vasopressin type
2 receptor; AVP, arginine-vasopressin; PDE, phosphodiesterase.
adenylate cyclase by forskolin. However, while our in
vitro data would support a post receptor effect of CaR
activation in inhibiting AQP2 translocation, it is possible
that, in vivo a Gi coupled pathway may also be involved.
Vasopressin activates sodium and water reabsorption in
the thick ascending limb and medullary collecting duct,
respectively, by increasing cAMP levels. These effects
are attenuated in the presence of high Ca2+o. The ex-
isting data, in rat tubules, based on the use of pertus-
sis toxin, support that a Gi coupled receptor activation
signaling may mediate the extracellular calcium effects
[40–42]. In some cells expressing CaR, CaR agonists can
inhibit cAMP accumulation through a mechanism involv-
ing a CaR-induced increase in [Ca2+]i which then inhibits
a calcium-sensitive form of adenylate cyclase [43]. This
mechanism may explain the reduction in cAMP levels.
Alternatively Ca2+-dependent increase in [Ca2+]i can im-
pair cAMP accumulation by an increase in cAMP hydrol-
ysis, through a Ca2+-mediated process [33, 34].
We also show here that treatment with 300 lmol/L
Gd3+ or with 5 mmol/L Ca2+o for 15 minutes caused ac-
tivation of PKCa and PKCε. The former belongs to the
conventional PKC isoforms that require calcium and dia-
cylglycerol (DAG) for activation while the latter belongs
to the novel PKC isoforms that are calcium-independent
but require DAG for activation. PKC can contribute to
the inhibitory effect of Ca2+o on forskolin-induced AQP2
targeting to the plasma membrane. Indeed, Van Balkom
et al [36] suggested that PKC activation may mediate en-
docytosis of AQP2 in renal cells.
Another intriguing effect of Ca2+o and Gd3+ in re-
nal CD8 cells was the activation of F-actin assembly.
We have recently demonstrated that cAMP-dependent
AQP2 translocation is associated with inhibition of
RhoA, which results in F-actin disassembly [25, 37, 43].
Conversely, we also have shown that the diuretic effect
of prostaglandin E2 (PGE2) on renal principal cells is
mediated by Rho activation resulting in F-actin assembly
[44].
We report here that, while forskolin or vasopressin
treatment induced a significant decrease in F-actin con-
tent (25%), 5 mmol/L calcium or Gd3+ treatment resulted
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in a nearly twofold increase in F-actin content compared
with basal conditions. Stabilization of cortical F-actin cy-
toskeleton may impair AQP2 targeting, as previously sug-
gested [38, 44]. We may speculate that F-actin assembly
is a result of Rho activation associated with CaR signal-
ing. Indeed, in HEK-293 cells transfected with CaR, a
CaR-mediated increase in membrane-associated RhoA
has been demonstrated, suggesting a CaR activation of
Rho [39]. Moreover, in HEK-293 cells it has been demon-
strated that Gaq and Gaq-coupled receptors activate
Rho and its downstream effectors [45, 46]. Interestingly,
Gaq is a G protein to which the CaR can couple [11, 47]
and AQP2-containing vesicles have been shown to pos-
sess Gaq [23].
Here, we speculate that F-actin assembly is a result of
Rho activation possibly associated with CaR signaling.
CONCLUSION
The data reported here provide the first physiologic
explanation for an effect of luminal calcium in kidney
inner medulla. Specifically, we demonstrated that lumi-
nal calcium antagonizes AQP2 translocation to the apical
plasma membrane through a reduction in cAMP levels,
activation of PKC and stabilization of actin cytoskele-
ton (see proposed model in Fig. 8). Given that the ob-
served effects could also be mediated by another CaR
agonist, Gd 3+, our observations suggest a role for a CaR-
mediated inhibition of the vasopressin response. Physi-
ologically, “sensing” the increase in urinary calcium by
CaR would reduce vasopressin-stimulated water reab-
sorption from urine to interstitial fluid. This response
would prevent further calcium concentration, thus pro-
tecting against a potential risk of calcium oxalate- or
calcium phosphate-containing kidney stone formation.
Further work using specific CaR modulators is necessary
to demonstrate unequivocally a role for the CaR in this
phenomenon.
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